ANNA Home Page
ANNA CE Link
HDCN Home Page
HDCN Registration Link

If you dont have an Acrobat Reader installed on your computer, you may download it for free from the link below:


Scleroderma: A Case Presentation
 (Vol 33/No. 1. On-line test expires: 02/20/2008)
To receive continuing education credit, you must read the information in this article and take an on-line post test and fill out an on-line program evaluation form. The certificate will then be generated for you as a .pdf file which you can print out locally on your computer.

CE Certification by ANNA requires a handling charge that must be paid by credit card. Pricing information is available by clicking on the "Post-Test Evaluation" link below.
  DOWNLOAD TEST ARTICLE
Please download and print the PDF file below:
  AUTHOR
Sara Otterness, RN, CNP, CNN,
 Sara Otterness, RN, CNP, CNN, is Renal Nurse Practitioner, VA Medical Center, Minneapolis, MN. She is a member of ANNA’s APN SIG and is Chapter President of ANNA’s Twin Cities Metro Chapter.
  OUTLINE

Editor’s Note:
The following article first appeared in Nephrology Nursing Journal (NNJ), volume 32, no. 4, pp. 454-456. This article has been updated and is now being offered with continuing education (CE) content for nephrology nurses.
  GET YOUR CE CERTIFICATE
Take on-line Quiz:
  CE RELATED INFORMATION
This offering for 1.0 contact hours is being provided by the American Nephrology Nurses’ Association (ANNA), which is accredited as a provider and approver of continuing education in nursing by the American Nurses’ Credentialing Center-Commission on Accreditation (ANCCCOA). This educational activity is approved by most states and specialty organizations that recognize the ANCC-COA accreditation process. ANNA is an approved provider of continuing education in nursing by the California Board of Registered Nursing, BRN Provider No. 00910; and the Kansas State Board of Nursing, Provider No. LT0148-0738. This offering is accepted for RN and LPN relicensure in Kansas

  EDUCATIONAL OBJECTIVES

Goal:
To highlight the manifestations and treatment plans for different manifestations of scleroderma.

 Objectives:
1. Relate the manifestations of scleroderma to the pathophysiological basis of the disease.
2. Describe a treatment plan for scleroderma renal disease.
3. Summarize the prognosis for patients with varying degrees of scleroderma.


AUTHOR DISCLOSURE STATEMENT
Sara Otterness, has no conflicts of interest to disclose.

 ANNA and HDCN CE POLICY STATEMENTS

The CE policy and disclosure statements of the American Nephrology Nurses' Association are given in detail on the Symposium Home Page. The CE policy statements of HDCN are listed on this page.